Elevance Health Inc. (ELV)
NYSE: ELV · IEX Real-Time Price · USD
500.12
-4.60 (-0.91%)
Jul 19, 2024, 4:00 PM EDT - Market closed

Elevance Health Revenue

Elevance Health had revenue of $171.96B in the twelve months ending June 30, 2024, with 3.77% growth year-over-year. Revenue in the quarter ending June 30, 2024 was $43.89B with 0.49% year-over-year growth. In the year 2023, Elevance Health had annual revenue of $171.34B with 9.42% growth.

Revenue (ttm)
$171.96B
Revenue Growth
+3.77%
P/S Ratio
0.67
Revenue / Employee
$1,639,266
Employees
104,900
Market Cap
115.97B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023171.34B14.75B9.42%
Dec 31, 2022156.60B17.96B12.95%
Dec 31, 2021138.64B16.77B13.76%
Dec 31, 2020121.87B17.65B16.94%
Dec 31, 2019104.21B12.11B13.15%
Dec 31, 201892.11B2.07B2.29%
Dec 31, 201790.04B5.18B6.10%
Dec 31, 201684.86B5.71B7.21%
Dec 31, 201579.16B5.28B7.15%
Dec 31, 201473.87B2.85B4.01%
Dec 31, 201371.02B9.53B15.49%
Dec 31, 201261.50B786.50M1.30%
Dec 31, 201160.71B2.01B3.43%
Dec 31, 201058.70B-6.24B-9.61%
Dec 31, 200964.94B3.69B6.02%
Dec 31, 200861.25B83.20M0.14%
Dec 31, 200761.17B4.11B7.20%
Dec 31, 200657.06B12.44B27.89%
Dec 31, 200544.61B23.91B115.44%
Dec 31, 200420.71B3.93B23.40%
Dec 31, 200316.78B3.49B26.25%
Dec 31, 200213.29B2.85B27.26%
Dec 31, 200110.44B1.67B19.08%
Dec 31, 20008.77B2.50B39.89%
Dec 31, 19996.27B587.70M10.34%
Dec 31, 19985.68B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cigna 206.00B
Pfizer 55.09B
Sanofi 51.60B
Medtronic 32.36B
Gilead Sciences 27.45B
Stryker 20.96B
Boston Scientific 14.71B
Regeneron Pharmaceuticals 13.10B
Revenue Rankings